Literature DB >> 2844233

Fluorescence indicates a calcium-dependent interaction between the lipopeptide antibiotic LY146032 and phospholipid membranes.

J H Lakey1, M Ptak.   

Abstract

LY146032 is one of the A21978C family of calcium-dependent antibiotics. This paper reports on its interactions with membranes as studied by its intrinsic fluorescence. The Trp residue was found to have a low fluorescence yield because of Förster-type energy transfer to the kynurenine residue (Kyn) (epsilon = 5000 at 364 nm). However, the Kyn fluorescence (lambda max = 465 nm in H2O) was a sensitive probe of the membrane interactions, and it was used in steady-state fluorescence measurements including fluorescence polarization anisotropy. Initial binding of the peptide to phospholipid vesicles occurs in calcium-free solutions. When calcium is added, the resulting 10-fold fluorescent enhancement and 15-nm blue shift show that it causes the antibiotic to penetrate further into the lipid bilayer. Calcium is bound with an association constant of 151 M-1, while a phospholipid titration in the presence of calcium gave an association constant of 5 x 10(3) M-1 for egg phosphatidylcholine. Magnesium and cadmium cause very slight fluorescence enhancements, but a more significant effect is caused by the trivalent lanthanide ions. Analysis of these data indicates that the calcium-selective site is on the peptide and that ion binding to the phospholipid headgroups has a secondary role. Comparison with the divalent cation dependent antibiotics bacitracin and amphomycin shows that LY146032 has a quite different activity and that a calcium-dependent membrane interaction could account for results obtained in vivo.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2844233     DOI: 10.1021/bi00413a009

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  34 in total

1.  Daptomycin-mediated reorganization of membrane architecture causes mislocalization of essential cell division proteins.

Authors:  Joe Pogliano; Nicolas Pogliano; Jared A Silverman
Journal:  J Bacteriol       Date:  2012-06-01       Impact factor: 3.490

2.  Assessment of two commercial susceptibility test methods for determination of daptomycin MICs.

Authors:  James H Jorgensen; Sharon A Crawford
Journal:  J Clin Microbiol       Date:  2006-06       Impact factor: 5.948

3.  Effects of reduced cation supplement recommendations (National Committee for Clinical Laboratory Standards) on daptomycin antistaphylococcal activity.

Authors:  R N Jones
Journal:  Antimicrob Agents Chemother       Date:  1989-09       Impact factor: 5.191

4.  Daptomycin disrupts membrane potential in growing Staphylococcus aureus.

Authors:  W E Alborn; N E Allen; D A Preston
Journal:  Antimicrob Agents Chemother       Date:  1991-11       Impact factor: 5.191

5.  Daptomycin-Phosphatidylglycerol Domains in Lipid Membranes.

Authors:  Mark A Kreutzberger; Antje Pokorny; Paulo F Almeida
Journal:  Langmuir       Date:  2017-11-13       Impact factor: 3.882

6.  Cardiolipin prevents membrane translocation and permeabilization by daptomycin.

Authors:  TianHua Zhang; Jawad K Muraih; Nasim Tishbi; Jennifer Herskowitz; Rachel L Victor; Jared Silverman; Stephanie Uwumarenogie; Scott D Taylor; Michael Palmer; Evan Mintzer
Journal:  J Biol Chem       Date:  2014-03-10       Impact factor: 5.157

7.  Impact of community-associated, methicillin-resistant Staphylococcus aureus on management of the skin and soft tissue infections in children.

Authors:  Kanokporn Mongkolrattanothai; Robert S Daum
Journal:  Curr Infect Dis Rep       Date:  2005-09       Impact factor: 3.725

8.  In vitro and in vivo activities of tigecycline (GAR-936), daptomycin, and comparative antimicrobial agents against glycopeptide-intermediate Staphylococcus aureus and other resistant gram-positive pathogens.

Authors:  Peter J Petersen; Patricia A Bradford; William J Weiss; Timothy M Murphy; P E Sum; Steven J Projan
Journal:  Antimicrob Agents Chemother       Date:  2002-08       Impact factor: 5.191

9.  An evaluation of a fluorometric method for determining binding parameters of drug-carrier complexes using mathematical models based on total drug concentration.

Authors:  Boontarika Chanvorachote; Ubonthip Nimmannit; Walaisiri Muangsiri; Lee Kirsch
Journal:  J Fluoresc       Date:  2009-04-08       Impact factor: 2.217

10.  Activity of daptomycin against recent North American isolates of Streptococcus pneumoniae.

Authors:  M I Restrepo; J A Velez; M L McElmeel; C G Whitney; J H Jorgensen
Journal:  Antimicrob Agents Chemother       Date:  2003-09       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.